Yıl: 2021 Cilt: 15 Sayı: 5 Sayfa Aralığı: 330 - 355 Metin Dili: İngilizce DOI: http://doi.org/10.25135/rnp.222.20.11.1890 İndeks Tarihi: 17-10-2021

Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective

Öz:
Abstract: Different species of the genus Selaginella are exploited for various ethnomedicinal purposes aroundthe globe; mainly to cure fever, jaundice, hepatic disorders, cardiac diseases, cirrhosis, diarrhea, cholecystitis,sore throat, cough of lungs, promotes blood circulation, removes blood stasis and stops external bleeding aftertrauma and separation of the umbilical cord. Though, high content of various phytochemicals has been isolatedfrom Selaginella species, flavonoids have been recognized as the most active component in the genus. Crudeextract and different bioactive compounds of this plant have revealed various in vitro bioactivities such as,antimicrobial, antiviral, anti-diabetic, anti-mutagenic, anti-inflammatory, anti-nociceptive, anti-spasmodic,anticancer and anti-Alzheimer. However, more studies into the pharmacological activities are needed, since noneof the professed bioactivity of this plant have ever been fully evaluated. Therefore, this review aims to discussthe evidence-based ethnomedicinal and ethnopharmacological uses, phytochemicals and bioactive potential ofSelaginella species. It will provide an updated knowledge for ethnobotanists, ethnopharmacologists and otherscientific communities to rethink over the possible usage of Selaginella in medicine. Moreover, furtherexplorations are needed to formulate a novel medicinal product from Selaginella extracts for the improvement ofhuman health, together with toxicity evaluations, necessary to ensure about the safety of these medicinallycophytes.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • [1] S. Singh and R. Singh (2015). A review on endemic Indian resurrecting Herb Selaginella bryopteris (L.) Bak ‘Sanjeevani’, Int. J. Pharm. Sci. Res. 6, 50-56.
  • [2] B. H. Han, H. J. Chi, Y. N. Han and K. S. Ryu (1972). Screening on the anti-inflammatory activity of crude drugs, Korean J. Pharmacog. 4, 205-209.
  • [3] H. Itokawa, S. Mihashi, K. Watanabe, H. Natsumoto and T. Hamanaka (1983). Studies on the constituents of crude drugs having inhibitory activity against contraction of the ileum caused by histamine or barium chloride. Screening test for the activity of commercially available crude drugs and the related plant materials. Shoyakugaku Zasshi 37, 223-228.
  • [4] C. A. Macfoy and A. M. Sama (1983). Medicinal plants in Pujehun district of Sierra Leone, J. Ethnopharmacol. 8, 215-223.
  • [5] D. S. Han, S. J. Lee and H. K. Lee (1984). Ethnobotanical survey in Korea. Proceedings of the Fifth Asian Symposium on Medicinal Plants and Spices 5, 125
  • [6] M. Winkelman (1986). Frequently used medicinal plants in Baja California. Norte J. Ethnopharmacol. 18, 109-131.
  • [7] V. Darias, L. Bravo, R. Rabanal, M. C. Sanchez, L. R. M. Gonzalez and P. A. M. Hernandez (1989). New contribution to the ethnopharmacological study of the Canary Islands, J. Ethnopharmacol. 25, 77- 92.
  • [8] K. Ono, H. Nakane, Z. M. Meng, Y. Ose, Y. Sakai and M. Mizuno (1989). Differential inhibitory effects of various herb extracts on the activities of reverse transcriptase and various deoxyribonucleic acid (DNA) polymerases, Chem. Pharm. Bull. 37, 1810-1812.
  • [9] C. C. Lin and W. S. Kan (1990). Medicinal plants used for the treatment of hepatitis in Taiwan. Am. J. Chinese. Med. 18, 35-43.
  • [10] Z. M. Meng, Y. Saki, Y. Ose, T. Sato, H. Nagase, H. Kito, M. Sato, M. Mizuno, K. Ono and H. Nakane (1990). Antimutagenic activity by the medicinal plants in traditional Chinese medicines, Shoyakugaku Zasshi 44, 225-229.
  • [11] R. C. Lin, A. L. Skaltsounis, E. Sequin, F. Tilleguin and M. Koch (1994). Phenolic constituents of Selaginella doederleinii, Planta. Med. 60, 168-170.
  • [12] P. G. S. Sá, X. P. Nunes, J. T. Lima, J. A. Siqueira-Filho, A. P. Fontana, J. S. Siqueira, L. J. Quintans- Júnior, P. K. F. Damasceno, C. R. C. Branco, A. Branco and J. R. G. S. Almeida (2012). Antinociceptive effect of ethanolic extract of Selaginella convoluta in mice, BMC. Complement. Altern. Med. 12, 187.
  • [13] R. M. Tryon and A. F. Tryon (1982). Ferns and allied plants with special reference to tropical America. Springer-Verlag, New York, DOI: https://doi.org/10.1007/978-1-4613-8162-4
  • [14] W. S. Judd, C. S. Campbell, E. A. Kellog and P. F. Stevens (1999). Plant systematics: a phylogenetic approach. Sunderland: Sinauer Associates, https://www.nhbs.com/plant-systematics-book-5
  • [15] R. Mukhopadhyay (2001). A review of the work on the genus Selaginella P. Beauv, Ind. Fern. J. 18, 1- 44.
  • [16] T. Chikmawati, A. Setyawan and D. Miftahudin (2008). Phytochemical content of Selaginella plant extracts on the island of Java Indonesia. 8th Seminar and Congress of Indonesian Association of Plant Taxonomy (PTTI). Cibinong Science Center, Bogor-Indonesia, pp. 21-23.
  • [17] G. L. Silva, H. Chai, M. P. Gupta, N. R. Farnsworth, G. A. Cordell, J. M. Pezzuto, C. W. Beecher and A. D. Kinghorn (1995). Cytotoxic biflavonoids from Selaginella willdenowii, Phytochemistry. 40, 129- 134.
  • [18] Y. M. Lin, M. T. Flavin, R. Schure, F. C. Chen, R. Sidwell, D. L. Barnard, J. H. Huffman and E. R. Kern (1999). Antiviral activities of bioflavonoids, Planta. Med. 65, 120-125.
  • [19] A.G. Mercader and A.B. Pomilio (2012). Biflavonoids: occurence, structural features and bioactivity. Nova Science Publisher, Inc. Hauppauge, New York.
  • [20] K. Kimura and Y. Noro (1965). Pharmacognostical studies on Chinese drug "Gu-sui-bu". I. consideration on"gu-sui-bu" in old herbals (Pharmacognostical studies on fern drugs XI), Syoy – akugaku Zasshi 19, 25-31.
  • [21] R. Antony and R. Thomas (2011). A mini review on medicinal properties of the resurrecting plant Selaginella bryopteris (Sanjeevani), Int. J. Pharma. Life Sci. 2, 933-939.
  • [22] L. R. Chao, E. Seguin, F. Tillequin and M. Koch (1987). New alkaloid glycosides from Selaginella doederleinii, J. Nat. Prod. 50, 422-426.
  • [23] H. Ishikawa (1974). Selaginella tamariscina. Hakkusha Ishikawa Haruhiko, Tokyo, Japan (8th printing; in Japanese). 186 pp.
  • [24] B. S. Kholia (2008). Selaginella bryopteris (L.) Bak. An endemic fern-ally of India under threat, Ind. Fern. J. 25, 73-78.
  • [25] J. R. G. Almeida, P. G. S. Sá, L. A. R. Macedo, J. A. Filho, V. R. Oliveira and J. M. B. Filho (2013). Phytochemistry of the genus Selaginella (Selaginellaceae), J. Med. Plant Res. 7, 1858-1868.
  • [26] J. B. Harbone and C. A. Williams (2000). Advances in flavonoid research since 1992, Phytochemistry 55, 481-504.
  • [27] M. F. Hu, M. H. Yen, J. W. Liao and K. L. Liu (2004). Hepatoprotective effects of the folk medicines of “Yan-Kan-Tang No.1” and “Yan- Kan-Tang No.2” on Rats, Crop. Environ. Bioinfo. 1, 229-238.
  • [28] J. Li, X. Lei and K. Chen (2014). Comparison of cytotoxic activities of extracts from Selaginella species, Pharmacogn. Mag. 10, 529-535.
  • [29] L. C. Lin and C. J. Chou (2000). Three new biflavonoids from Selaginella delicatula, Chin. Pharm. J. 52, 211-218.
  • [30] D. H. Che and J. G. Yu (1986). Analysis on the chemical constituents of jiangnanjuanbai (Selaginella moellendorffii Hieron). Chung Ts'aoYa. 17, 4.
  • [31] R. C. Swamy, O. Kunert, W. Schuhly, F. Bucar, D. Ferreira, V. S. Rani, B. R. Kumar and A. V. N. A. Rao (2006). Structurally unique biflavonoids from Selaginella chrysocaulos and Selaginella bryopteris, Chem. Biodivers. 3, 405-413.
  • [32] J. Li, D. R. Wan and K. L. Chen (2007). RAPD analysis of 8 medicinal species of Selaginella, Zhong Yao Cai 30, 403-406.
  • [33] J. C. Xu, X. Q. Liu and K. L. Chen (2009). A new biflavonoid from Selaginella labordei Hieron. ex Christ, Chinese Chem. Lett. 20, 939-941.
  • [34] J. W. Yang, Y. R. Pokharel, M. R. Kim, E. R. Woo, H. K. Choi and K. W. Kang (2006). Inhibition of inducible nitric oxide synthase by sumaflavone isolated from Selaginella tamariscina, J. Ethnopharmacol. 105, 107-113.
  • [35] J. A. Lopez-Saez, M. J. Perez-Alonso and A. V. Negueruela (1994). Biflavonoids of Selaginella denticulate growing in Spain, Z. Naturforsch. C. 49, 267-270.
  • [36] M. I. Aguilar, M. G. Romero, M. I. Chávez, B. King-Díaz and B. Lotina-Hennsen (2008). Biflavonoids isolated from Selaginella lepidophylla inhibit photosynthesis in spinach chloroplasts, J. Agric. Food Chem. 56, 6994-7000.
  • [37] P. C. Kam and A. Liew (2002). Traditional Chinese herbal medicine and anaesthesia, Anaesthesia 57, 1083-1089.
  • [38] D. F. Rhoades (1979). Evolution of plant chemical defense against herbivores. In Rosenthal GAD, Janzen H (eds.), Herbivores, their interaction with secondary plant metabolites. Academic Press, New York. pp. 3-54.
  • [39] T. Chikmawati, A. D. Setyawan and Miftahudin (2012). Phytochemical composition of Selaginella sp. from Java Island Indonesia, Makara J. Sci. 16, 129-133.
  • [40] N. Y. Lee, H. Y. Min, J. Lee, J. W. Nam, Y. J. Lee, A. R. Han, A. Wiryawan, W. Suprapto, S. K. Lee and E. K. Seo (2008) Identification of a new cytotoxic biflavone from Selaginella doederleinii, Chem. Pharm. Bull. 56, 1360-1361.
  • [41] J. K. Weng and J. P. Noel (2013). Chemodiversity in Selaginella: a reference system for parallel and convergent metabolic evolution in terrestrial plants, Front. Plant Sci. 4, 1-17.
  • [42] Y. F. Bi, X. F. Zheng, W. S. Feng and S. P. Shi (2004). Isolation and structural identification of chemical constituents from Selaginella tamariscina (Beauv.) Spring. Yao XueXueBao 39, 41-45.
  • [43] S. C. Ma, P.P. But, V.C. Ooi, Y. H. He, S. S. Lee, S. F. Lee and R. C. Lin (2001). Antiviral amentoflavone from Selaginella sinensis, Biol. Pharm. Bull. 24, 311-312.
  • [44] S. Suganya, V. Irudayaraj and M. Johnson (2011). Pharmacognostical studies on an endemic Spike- Moss Selaginella tenera (Hook. & Grev.) Spring from the Western Ghats, South India, J. Chem. Pharm. Res. 3, 721-731.
  • [45] M. A. Dahlen (1988). Taxonomy of Selaginella: a study of characters, techniques, and classification in the Hong Kong species, Bot. J. Linn. 98, 277-302.
  • [46] S. Czeladzinski (2003). Selaginella at the Barbican, Plant Herit. 10, 472-476.
  • [47] L. C. Lin, Y. C. Kuo and C. J. Chou (2000). Cytotoxic biflavonoids from Selaginella delicatula, J. Nat. Prod. 63, 627-630.
  • [48] P. L. Chiu, G. W. Patterson and T. A. Salt (1988). Sterol composition of pteridophytes, Phytochemistry 27, 819-822.
  • [49] A. W. Murray, M. J. Solomon and M. W. Kirschner (1989). The role of cyclin synthesis and degradation in the control of maturation promoting factor activity, Nature 339, 280-286.
  • [50] X. K. Zheng, S. P. Shi, Y. F. Bi, W. S. Feng, J. F. Wang and J. Z. Niu (2004a). The isolation and identification of a new lignanoside from Selaginella tamariscina (Beauv.) Spring. Yao XueXueBao 39, 719-721.
  • [51] X. K. Zheng, L. Zhang, W. W. Wang, Y. Y. Wu, Q. B. Zhang and W. S. Feng (2011). Anti-diabetic activity and potential mechanism of total flavonoids of Selaginella tamariscina (Beauv.) Spring in rats induced by high fat diet and low dose STZ, J. Ethnopharmacol. 137, 662-668.
  • [52] J. K. Singh, R. Kumari, M. D. Obaidullah and A. M. Jha (2014). Effect of Selaginella bryopteris on diabetic swiss albino mice caused by alloxan, Int. J. Basic Appl. Sci. Res. 1, 22-27.
  • [53] S. Y. Shim, S. G. Lee and M. Lee (2018). Biflavonoids isolated from Selaginella tamariscina and their anti-inflammatory activities via ERK 1/2 Signaling, Molecules 23, 926.
  • [54] A. N. Won, S. A. Kim, J. Y. Ahn, J. H. Han, C. H. Kim, J. H. Lee and D. I. Kim (2018). HO-1 induction by Selaginella tamariscina extract inhibits inflammatory response in lipopolysaccharide-stimulated RAW 264.7 macrophages, Evid. Based Complement. Altern. Med. Article ID 7816923.
  • [55] P. Zhao, K. L. Chen, G. L. Zhang, G. R. Deng and J. Li (2017). Pharmacological basis for use of Selaginella moellendorffii in gouty arthritis: antihyperuricemic, anti-inflammatory, and xanthine oxidase inhibition. Evid. Based Complementary Altern. Med. Article ID 2103254
  • [56] P. Belle, M. F. Eya’ane, K. Lebogang, E. Laure, Z. C. Bogning, A. Antoinette, E. A. M. Hamza, A. B. Dongmo and M. Malik (2018). Eco-friendly synthesis, characterization, in vitro and in vivo antiinflammatory activity of silver nanoparticle-mediated Selaginella myosurus aqueous extract, Int. J. Nanomed. 13, 8537-8548.
  • [57] M. Verma, M. Gangwar, M. Sahai, G. Nath and T. Singh (2015). Antimicrobial activity of phytochemicals isolated from Selaginella bryopteris, Chem. Nat. Com. 51, 341-345.
  • [58] W. Gang, L. S. Hua, Z. H. Lian, J. Y. Mei, S. M. Mei, Y. L. Jiang and Z. X. Mei (2017). Phytochemical screening, antioxidant, antibacterial and cytotoxic activities of different extracts of Selaginella dederleinii, Bangladesh J. Bot. 46, 1193-1201.
  • [59] S. Nallaiyan and H. Doraiswamy (2011). Phytochemical activity of leaves of Selaginella involvens and Selaginella inaequalifolia extracts on poultry pathogens, Int. J. Curr. Res. 3, 065-068.
  • [60] V. Irudayaraj, M. Janaky, M. Johnson and N. Selvan (2010). Preliminary phytochemical and antimicrobial studies on a spike-moss Selaginella inaequalifolia (Hook. & Grev.) Spring, Asian Pac. J. Trop. Med. 3, 957-960.
  • [61] L. A. R. Macêdo, R. G. O. Júnior, G. R. Souza, A. P. de Oliveira, E. M. de Lavor, M. G. Silva, A. G. M. Pacheco, I. R.A. de Menezes, H. D. M. Coutinho, C. O. Pessoa, M. P. da Costa and J. R. G. da Silva Almeida (2018). Chemical composition, antioxidant and antibacterial activities and evaluation of cytotoxicity of the fractions obtained from Selaginella convoluta (Arn.) Spring (Selaginellaceae), Biotechnol. Equip. 32, 506-512.
  • [62] S. Choi, K. Y. Lee, E. J. Jang, S. M. Cha and J. D. Cha (2019). Antimicrobial activity of Selaginella tamariscina extract against oral bacteria, Dent. Oral Craniofac. Res. 5, 1-7.
  • [63] T. P. A. Devasagayam, J. C. Tilak, K. K. Boloor, K. S. Sane, S. S. Ghaskadbi and R. D. Lele (2004). Free radicals and antioxidants in human health: current status and future prospects, J. Assoc. Physicians India 52, 794-804.
  • [64] E. J. Middleton, C. Kandaswami and T. C. Theoharides (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer, Pharmacol. Rev. 52, 673- 751.
  • [65] N. K. Sah, S. N. P. Singh, S. Sahdev, S. Banerji, V. Jha, Z. Khan and S. E. Hasnain SE (2005). Indian herb ‘Sanjeevani’ (Selaginella bryopteris) can promote growth and protect against heat shock and apoptotic activities of ultra violet and oxidative stress, J. Biosci. 30, 499-505.
  • [66] N. Miao, H. Tao, C. Tong, H. Xuan and G. Zhamg (1996). The Selaginellata mariscina (Beauv.) Spring complex in the treatment of experimental diabetes and its effect on blood rheology, China J. Chinese Mat. Med. 21, 493-495.
  • [67] V. Gayathri, V. V. Asha and A. Subramoniam (2005). Preliminary studies on the immunomodulatory and antioxidant properties of Selaginella species, Ind. J. Pharmacol. 37, 381-385.
  • [68] S. Li, R. Zhu, M. Zhong, Y. Zhang, K. Huang, X. Zhi and S. Fu (2010). Effects of ultrasonic-assistant extraction parameters on total flavones yield of Selaginella doederleinii and its antioxidant activity, J. Med. Plant Res. 4, 1743-1750.
  • [69] A. D. Setyawan (2011). Natural products from genus Selaginella (Selaginellaceae), Biosci. 3, 44-58.
  • [70] K. Chen, G. W. Plumb, R. N. Bennett and Y. Bao (2005). Antioxidant activities of extracts from five anti-viral medicinal plants, J. Ethnopharmacol. 96, 201-205.
  • [71] B. K. Chakravarthy, Y. Y. Rao, S. S. Gambhir and K. D. Gode (1981). Isolation of amentoflavone from Selaginella rupestris and its pharmacological activity on central nervous system, smooth muscles and isolated frog heart preparations, Planta Med. 43, 64-70.
  • [72] H. S. Lee, W. K. Oh, B. K. Kim, S. C. Ahn, D. O. Kang, D. I. Shin, J. Kim, T. I. Mheen and S. Ahn (1996). Inhibition of phospholipase C gamma 1 activity by amentoflavone isolated from Selaginella tamariscina, Planta Med. 62, 293-96.
  • [73] A. Rojas, M. Bah, J. I. Rojas, V. Serrano and S. Pacheco (1999). Spasmolytic activity of some plants used by the Otomi Indians of Querétaro (México) for the treatment of gastrointestinal disorders, Phytomedicine 6, 367-371.
  • [74] H. Lee and J. Y. Lin (1988). Antimutagenic activity of extracts from anticancer drugs in Chinese medicine, Mutat. Res. Genet. Toxicol. 204, 229-234.
  • [75] H. D. Yin, N. W. Ning, X. Z. Zhen, Z. Lin, P. X. Kang, F. C. Alex, S. C. Dong and S. T. Gui (2017). Multi-target screening and experimental validation of natural products from Selaginella plants against Alzheimer's disease, Front. Pharmacol. 8, 539.
  • [76] L. A. R. Oliveira-Macêdo, A. G. M. Pacheco, S. R. G. Lima-Saraiva, J. C. Silva, R. G. Oliveira-Júnior, G. R. Souza and V. R. Oliveira (2020). Fractions of Selaginella convoluta (Arn.) Spring (Selaginellaceae) attenuate the nociceptive behavior events in mice, Brazilian J. Biol. 80, 57-65.
  • [77] J. T. Priscilla, S. Geethaa, S. Sreeramanan and M. T. Ong (2014). Brine shrimp lethality test and antiproliferation test against human cancer-origin cell lines using ethanolic and water extracts of Selaginella doederleinii Hieron, J. Biomed. Pharma. Res. 3, 63-69.
  • [78] S. F. Yang, S. C. Chu, S. J. Liu, Y. C. Chen, Y. Z. Chang and Y. S. Hsieh (2007). Antimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in vivo, J. Ethanopharmacol. 110, 483-90.
  • [79] I. S. Lee, A. Nishikawa, F. Furukawa, K. Kasahara and S. U. Kim (1999). Effects of Selaginella tamariscina on in vitro tumor cell growth, p53 expression, G1 arrest and in vivo gastric cell proliferation, Cancer Lett. 144, 93-99.
  • [80] J. S. Lee, M. S. Lee, W. K. Oh and J. Y. Sul (2009). Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells, Biol. Pharm. Bull. 32, 1427-1432.
  • [81] Y. Jing, G. Zhang, M. Enlong, H. Zhang, J. Guan and J. He (2010). Amentoflavone and the extracts from Selaginella tamariscina and their anticancer activity, Chin. Herb. Med. 5, 226-229.
  • [82] G. Guruvayoorappan and G. Kuttan (2007). Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F-10 melanoma cells in C57BL/6 mice, Integr. Cancer Ther. 6, 185-197.
  • [82] S. Handayani, A. Hermawan, E. Meiyanto and Z. Udin (2013). Induction of apoptosis on MCF-7 cells by Selaginella fractions, J. Appl. Pharm. Sci. 3, 31-34.
  • [84] P. Chen, J. Y. Sun, N. G. Xie and Y. G. Shi (1995). Chemical constituents of daeycai (Selaginella doederleinii). Zhong Cao Yao 26, 397-399.
  • [85] K. Y. Pan, J. L. Lin and J. S. Chen (2001). Severe reversible bone marrow suppression induced by Selaginella doederleinii, Clin. Toxicol. 39, 637-639.
  • [86] I. R. Lee, J. Y. Song and Y. S. Lee (1992). Cytotoxicity of folkloric medicines in murine and human cancer cells, Kor. J. Pharmacog. 23, 132-136.
  • [87] S. Perez, R. M. Perez, C. Perez, M. A. Zavala and R. Vargas (1994). Inhibitory activity of 3- methylenhydroxy-5-methoxy-2, 4-dihydroxy tetrahydrofurane isolated from Selaginella lepidophylaon smooth muscle of Wistar rat, Pharm. Acta. Hel. 69, 149-152.
  • [88] L. Y. Ma, F. Wei, S. C. Ma and R. C. Lin (2002). Two new chromone glycosides from Selaginella uncinata, Chin. Chem. Lett. 13, 748-751.
  • [89] L. Y. Ma, S. C. Ma, F. Wei, R. C. Lin, P. P. H. But and S. F. Lee (2003). Uncinoside A and B, two new antiviral chromone glycosides from Selaginella uncinata, Chem. Pharm. Bull. 51, 1264-1267.
  • [90] X. K. Zheng, K. K. Li, Y. Z. Wang and W. S. Feng (2008). A new dihydrobenzofuranlignanoside from Selaginella moellendorffii Hieron, Chin. Chem. Lett. 19, 79-81.
  • [91] T. M. Zhu, K. L. Chen and W. B. Zhou (2008). A new flavones glycoside from Selaginella moellendorffii Hieron. Chinese Chem. Lett. 19, 1456-1458.
  • [92] J. Kim and E. J. Park (2002). Cytotoxic anticancer candidates from natural resources, Curr. Med. Chem. Anti. Cancer Agents.2, 485-537.
  • [93] Y. H. Wang, C. L. Long, F. M. Yang, X. Wang, Q. Y. Sun, H. S. Wang, Y. N. Shi and G. H. Tang (2009). Pyrrolidinoindoline alkaloids from Selaginella moellendorfii, J. Nat. Prod. Res. 72, 1151-1154.
  • [94] Y. Cao, J. J. Chen, N. H. Tan, L. Oberer, T. Wagner, Y. P. Wu, G. Z. Zeng, H. Yan and Q. Wang (2010). Antimicrobial selaginellin derivatives from Selaginella pulvinata, Bioorg. Med. Chem. Lett. 20, 2456-2460.
  • [95] Y. Cao, J. J. Chen, N. H. Tan, Y. P. Wu, J. Yang and Q. Wang (2010). Structure determination of selaginellins G and H from Selaginella pulvinate by NMR spectroscopy, Magn. Reson. Chem. 48, 656- 659.
  • [96] Y. Cao, N. H. Tan, J. J. Chen, G. Z. Zeng, Y. B. Ma, Y. P. Wu, H. Yan, J. Yang, L. F. Lu and Q. Wang (2010). Bioactive flavones and biflavones from Selaginella moellendorffii Hieron, Fitoterapia 81, 253- 258.
  • [97] C. M. Sun, S. L. Yu, J. C. Ou and W. J. Syu (1995). Test of biflavones from Selaginella moellendorffii on the in vitro inhibition of HIV-1 protease, J. Chin. Med. 6, 223-230.
  • [98] C. M. Sun, W. J. Syu, Y. T. Huang, C. C. Chen and J. C. Ou (1997). Selective cytotoxicity of ginkgetin from Selaginella moellendorfiii J. Nat. Prod. 60, 382-384.
  • [99] W. S. Feng, K. K. Li and X. K. Zheng (2011). A new norlignanlignanoside from Selaginella moellendorfii Hieron, Acta. Pharmaceut. Sin. B. 1, 36-39.
  • [100] E. R. Woo, J. Y. Lee, I. J. Cho, S.G. Kim and K. W. Kang (2005). Amentoflavone inhibits the induction of nitric oxide synthase by inhibiting NF-kappa B activation in macrophages, Pharmacol. Res. 51, 539- 546.
  • [101] P. Rupa and N. L. Bhavani (2014). Preliminary phytochemical screening of desiccated fronds of Selaginella bryopteris (L.) Baker (Pittakalu), World J. Pharma. Res. 3, 1370-1378.
  • [102] X. Zheng, D. F. Liao, B. Y. Zhu, Q. H. Tuo and Y. L. Xu (2001). Study on chemical constituents of Selaginella pulvinata, Zhong Cao Yao 32, 17-18.
  • [103] X. Zheng, J. Du, Y. Xu, B. Zhu and D. Liao (2007). A new steroid from Selaginella pulvinata. Fitoterapia 78, 598-599.
  • [104] X. K. Zheng, Y. F. Bi, W. S. Feng, J. F. Wang and J. Z. Niu (2004). Study on chemical constituents of Selaginella tamariscina (Beauv.) Spring, Yao XueXueBao 39, 266-268.
  • [105] D. I. Shin and J. W. Kim (1991). Flavonoid constituents of Selaginella tamariscina, Korean J. Pharmacog. 22, 207-210.
  • [106] J. F. Liu, K. P. Xu, D. J. Jiang, F. S. Li, J. Shen, Y. J. Zhou, P. S. Xu, B. Tan and G. S. Tan (2009). A new flavonoid from Selaginella tamariscina, Chinese Chem. Lett. 20, 595-597.
  • [107] J. F. Liu, K. P. Xu, F. S. Li, J. Shen, C. P. Hu, H. Zou, F. Yang, G. R. Liu, H. L. Xiang, Y. L. Zhou, Y. J. Li and G. S. Tan (2010). A new flavonoid from Selaginella tamariscina (Beauv.) Spring, Chem. Pharm. Bull. 58, 549-551.
  • [108] X. L. Cheng, S. C. Ma, J. D. Yu, S. Y. Yang, X. Y. Xiao, J. Y. Hu, Y. Lu, P. C. Shaw, P. P. Butt and R. C. Lin (2008). Selaginellin A and B, two novel natural pigments isolated from Selaginella tamariscina, Chem. Pharm. Bull. 56, 982-984.
APA Adnan M, Siddiqui A, Jamal A, hamadou w, Mahgoub D, Sachidanandan M, Patel D (2021). Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. , 330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
Chicago Adnan Mohd,Siddiqui Arif Jamal,Jamal Arshad,hamadou walid sabri,Mahgoub Dr. Amir,Sachidanandan Manojkumar,Patel Dr. Mitesh Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. (2021): 330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
MLA Adnan Mohd,Siddiqui Arif Jamal,Jamal Arshad,hamadou walid sabri,Mahgoub Dr. Amir,Sachidanandan Manojkumar,Patel Dr. Mitesh Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. , 2021, ss.330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
AMA Adnan M,Siddiqui A,Jamal A,hamadou w,Mahgoub D,Sachidanandan M,Patel D Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. . 2021; 330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
Vancouver Adnan M,Siddiqui A,Jamal A,hamadou w,Mahgoub D,Sachidanandan M,Patel D Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. . 2021; 330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
IEEE Adnan M,Siddiqui A,Jamal A,hamadou w,Mahgoub D,Sachidanandan M,Patel D "Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective." , ss.330 - 355, 2021. http://doi.org/10.25135/rnp.222.20.11.1890
ISNAD Adnan, Mohd vd. "Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective". (2021), 330-355. https://doi.org/http://doi.org/10.25135/rnp.222.20.11.1890
APA Adnan M, Siddiqui A, Jamal A, hamadou w, Mahgoub D, Sachidanandan M, Patel D (2021). Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. Records of Natural Products, 15(5), 330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
Chicago Adnan Mohd,Siddiqui Arif Jamal,Jamal Arshad,hamadou walid sabri,Mahgoub Dr. Amir,Sachidanandan Manojkumar,Patel Dr. Mitesh Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. Records of Natural Products 15, no.5 (2021): 330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
MLA Adnan Mohd,Siddiqui Arif Jamal,Jamal Arshad,hamadou walid sabri,Mahgoub Dr. Amir,Sachidanandan Manojkumar,Patel Dr. Mitesh Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. Records of Natural Products, vol.15, no.5, 2021, ss.330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
AMA Adnan M,Siddiqui A,Jamal A,hamadou w,Mahgoub D,Sachidanandan M,Patel D Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. Records of Natural Products. 2021; 15(5): 330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
Vancouver Adnan M,Siddiqui A,Jamal A,hamadou w,Mahgoub D,Sachidanandan M,Patel D Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective. Records of Natural Products. 2021; 15(5): 330 - 355. http://doi.org/10.25135/rnp.222.20.11.1890
IEEE Adnan M,Siddiqui A,Jamal A,hamadou w,Mahgoub D,Sachidanandan M,Patel D "Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective." Records of Natural Products, 15, ss.330 - 355, 2021. http://doi.org/10.25135/rnp.222.20.11.1890
ISNAD Adnan, Mohd vd. "Evidence-Based Medicinal Potential and Possible Role of Selaginella in the Prevention of Modern Chronic Diseases: Ethnopharmacological and Ethnobotanical Perspective". Records of Natural Products 15/5 (2021), 330-355. https://doi.org/http://doi.org/10.25135/rnp.222.20.11.1890